Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: a population-based case-control study in China

Cancer Lett. 2009 Mar 8;275(1):102-8. doi: 10.1016/j.canlet.2008.10.017. Epub 2008 Nov 25.

Abstract

The TGF-beta signaling pathway plays a very important role in the control of cell proliferation and differentiation that is involved in colorectal carcinogenesis. The associations between polymorphisms of TGF-beta1 and its receptors genes and the colorectal cancer risk were assessed in a population-based case-control study (206 cases and 838 controls). We could not observe any variant in the G-800A, codon25 and codon263 of TGF-beta1 and A-364G of TGFbetaR2 in Chinese population. However, the results revealed that -509CT and TT genotypes were significantly associated with decrease risk for colorectal cancer (adjusted OR=0.58, 95% CI 0.40-0.84 and adjusted OR=0.44, 95% CI 0.29-0.68, respectively). Moreover, the linkage disequilibrium analysis revealed that TGF-beta1 C-509T and codon10 polymorphisms were in strong linkage disequilibrium, and the -509C/+29C was associated with a significantly increased risk of colorectal cancer (OR=1.32, 95% CI=1.05-1.66). Our findings indicate that the distributions of polymorphisms in TGF-beta1 and its receptors genes vary greatly among different ethnic groups, and these polymorphisms might contribute to the colorectal cancer susceptibility.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • China
  • Colorectal Neoplasms / diagnosis*
  • Colorectal Neoplasms / ethnology
  • Colorectal Neoplasms / genetics*
  • Female
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Receptors, Transforming Growth Factor beta / metabolism
  • Transforming Growth Factor beta1 / metabolism*

Substances

  • Receptors, Transforming Growth Factor beta
  • Transforming Growth Factor beta1